Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Mulls Granting Regulated Industry Flexibility To Respond To Misinformation
Jan 11 2023
•
By
Sarah Karlin-Smith
FDA Commissioner Califf hints at more permissive sponsor communication to address misinformation • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Marketing & Advertising
More from Compliance